 |
인쇄하기
취소
|
Dongkook wins patent for sustained-release leuprorelin preparation
Dongkook Pharmaceutical Co. says it has acquired a Korean patent for sustained-release leuprorelin preparation using a biodegradable polymer.
The patent technology is characterized by releasing in the body leuprorelin acetate in the form of microparticle for two months, according to the company.
Leuprolide acts as an agonist at pituitary GnRH receptors. By interrupting the normal pulsatil...
The patent technology is characterized by releasing in the body leuprorelin acetate in the form of microparticle for two months, according to the company.
Leuprolide acts as an agonist at pituitary GnRH receptors. By interrupting the normal pulsatil...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.